Amanote Research
Register
Sign In
Idarucizumab Dosing in Patients With Excessive Dabigatran Body Burden
British Journal of Anaesthesia
- United Kingdom
doi 10.1016/j.bja.2018.10.027
Full Text
Open PDF
Abstract
Available in
full text
Categories
Anesthesiology
Pain Medicine
Date
February 1, 2019
Authors
L. Yip
J.F. Deng
Publisher
Elsevier BV
Related search
Idarucizumab Dosing in Kidney Failure
American Journal of Kidney Diseases
Nephrology
Idarucizumab for the Reversal of Dabigatran in Patients Undergoing Heart Transplantation
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Safety of Pulmonary Vein Isolation in Atrial Fibrillation Patients Treated With Dabigatran When Idarucizumab Is Available (RCDD Code: VIII)
Journal of Rare Cardiovascular Diseases
Cardiovascular Medicine
Cardiology
Adverse Clinical Outcomes After Dabigatran Reversal With Idarucizumab to Facilitate Acute Stroke Thrombolysis
Journal of Neurology
Neurology
Idarucizumab Resistance Due to a Markedly Elevated Dabigatran Concentration – A Case Report
Pathology
Forensic Medicine
Pathology
Idarucizumab for Urgent Reversal of Dabigatran for Heart Transplant: A Case Report
American Journal of Hematology
Hematology
Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke
Frontiers in Neurology
Neurology
Successful Intravenous Thrombolysis for Ischemic Stroke After Reversal of Dabigatran Anticoagulation With Idarucizumab: A Case Report
Journal of Medical Case Reports
Medicine
Life-Threatening Bleeding in Four Patients With an Unusual Excessive Response to Dabigatran: Implications for Emergency Surgery and Resuscitation
Thrombosis and Haemostasis
Hematology
